Clinical Trial Update: ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults [Phase 3]

View source ↗

Summary

This update notes the completion and posting of results for Phase 3 ALK21-003 evaluating Medisorb Naltrexone (Vivitrol) in adults with alcohol dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholism

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Alcoholism | Phase 3 | Status: COMPLETED | Results posted: 2010-12-07